Clinical Trial Update: Evaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumors or Non Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

A completed Phase 1 trial evaluating the safety and tolerability of GDC-0349 in patients with locally advanced or metastatic solid tumors or Non-Hodgkin's lymph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma
• Solid Tumor

Drugs mentioned

• GDC-0349

Snippet

Sponsor: Genentech, Inc. | Conditions: Non-Hodgkin's Lymphoma, Solid Tumor | Phase 1 | Status: COMPLETED